P

Paragon Biosciences

23 employees

Paragon Biosciences is a global healthcare company committed to accelerating biomedical research.

Investor insights

Sectors invested in

Biopharma3
Pharmaceutical3
Biotechnology3
Dermatology2
Life Science2
Clinical research2
Genetics2
Epidermolysis Bullosa2
Life sciences2
Pediatric disease2
Orphan drug2
Drug development2
Bioscience2
Localized Scleroderma2
Gene therapy2
Personalized medicine2
Rare disease2
Therapeutics1
Innovation1
Biopharmaceutical1

Funding rounds participated in

$113M sweet spot round size

Most of their 3 investments are in rounds between $55M and $113M

Investor type

Accelerator
Incubator

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Pharmaceutical
Life Science

Date founded

2010

Investments made

E

Emalex Biosciences raised $250M on November 3, 2022

Investors: Valor Equity Partners and Paragon Biosciences

C

Castle Creek Biosciences, Inc. raised $113M on May 2, 2022

Investors: Valor Equity Partners and Paragon Biosciences

C

Castle Creek Biosciences, Inc. raised $55M on March 25, 2020

Investors: Valor Equity Partners and Paragon Biosciences

FAQ